EMGALITY 120 MG 1 PEN

EMGALITY 120 MG 1 PEN

2,343.00 

*recommended price

Find out how to buy and cost EMGALITY 120 MG 1 PEN in Europe you can make a request on the site.
We will help in the preparation of customs documents and accompanying documentation for delivery EMGALITY 120 MG 1 PEN , get permission from airport security.

Foreign citizens who purchase drugs while in Israel can receive a refund of VAT (TAX FREE) upon departure at the airport

Manufacturer: Eli Lilly Israel
Amount in a package: 1
Manufacturer’s website link
Description: EMGALITY 120 MG 1 PEN is an injectable medication designed for the prevention of migraines in adult patients. It belongs to the category of medicines that help prevent or reduce the frequency and intensity of migraine attacks. The medication contains the active ingredient galcanezumab, which blocks the action of the protein CGRP, known as one of the main pain mediators in migraines. EMGALITY 120 MG 1 PEN is a convenient form of administration that allows patients to self-administer injections at home. It is recommended for monthly use and can reduce the frequency of migraine attacks by up to 50%. The medication should only be used as directed by a doctor and is not intended for the treatment of acute migraine attacks.
EMGALITY is a highly effective medication for treating migraines. It is a convenient and reliable option for those who suffer from this debilitating condition. Purchasing EMGALITY online offers numerous benefits, such as the convenience of ordering from the comfort of your own home and having it delivered directly to your doorstep. Additionally, buying EMGALITY online often allows for lower prices and discounts, making it a more cost-effective option. With the ease and accessibility of online shopping, there is no reason to delay getting the relief you need from migraines. Trust in the convenience and affordability of purchasing EMGALITY online.

Reviews

There are no reviews yet.

Be the first to review “EMGALITY 120 MG 1 PEN”

Your email address will not be published.